NEU 0.36% $19.43 neuren pharmaceuticals limited

Surprised at the nervousness being expressed. Unlike the Trof Ph...

  1. 371 Posts.
    lightbulb Created with Sketch. 1095
    Surprised at the nervousness being expressed. Unlike the Trof Ph 3 results this is not a do or die moment for Neuren.

    No matter what the results are Neuren will be a successful profitable company ongoing. This is true even if the results are terrible.

    I'm sure excited to see the results. But I'm not at all scared because there is only upside potential.

    Why? Because Neurens market valuation already attributes zero value to NNZ-2591. You can't go much lower than zero.

    Besides, in case anyone forgot, this is only the first of 4 trial results - if it fails we are down to max 3 out of 4 instead of 4 of 4. I absolutely love these odds
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.